PREDICTING THE POTENTIAL FOR CANNABIDIOL INDUCED DRUG-DRUG INTERACTIONS WITH MAJOR CYP450 ENZYMES USING MODEL-BASED APPROACHES

被引：0
|
作者：
Eltanameli, B. [1 ]
Al Sahlawi, S. [1 ]
Cicali, B. [1 ]
Cristofoletti, R. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
LB-032
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [41] Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
    Obach, R. Scott
    Walsky, Robert L.
    Venkatakrishnan, Karthik
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) : 246 - 255
  • [42] Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning
    Kastrin, Andrej
    Ferk, Polonca
    Leskosek, Brane
    PLOS ONE, 2018, 13 (05):
  • [43] PREDICTION OF POTENTIAL-DRUG INTERACTIONS USING CYP450 INHIBITION SPECTRA FOR D2916 AND D3187
    MATHER, GG
    KUNZE, KL
    HARR, JE
    LEPAGE, F
    LEVY, RH
    EPILEPSIA, 1995, 36 : 253 - 253
  • [44] Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug-drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling
    Chen, Jia
    Liu, Dongyang
    Zheng, Xin
    Zhao, Qian
    Jiang, Ji
    Hu, Pei
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 857 - 868
  • [45] Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model
    Almond, Lisa M.
    Mukadam, Sophie
    Gardner, Iain
    Okialda, Krystle
    Wong, Susan
    Hatley, Oliver
    Tay, Suzanne
    Rowland-Yeo, Karen
    Jamei, Masoud
    Rostami-Hodjegan, Amin
    Kenny, Jane R.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (06) : 821 - 832
  • [46] Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions
    Raffa, Robert B.
    Taylor, Robert, Jr.
    Pergolizzi, Joseph V., Jr.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (03) : 361 - 371
  • [47] ASSESSING POTENTIAL DRUG-DRUG INTERACTIONS INVOLVING Δ-9-TETRA HYDROCANNABINOL AND CANNABIDIOL IN HEALTHY ADULTS USING PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    Qian, L.
    Zhang, T.
    Dinh, J.
    Paine, M.
    Zhou, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S27 - S28
  • [48] Biotransformation of the Mycotoxin Enniatin B1 by CYP P450 3A4 and Potential for Drug-Drug Interactions
    Ivanova, Lada
    Denisov, Ilia G.
    Grinkova, Yelena, V
    Sligar, Stephen G.
    Faeste, Christiane K.
    METABOLITES, 2019, 9 (08)
  • [49] Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro
    Sorf, Ales
    Hofman, Jakub
    Kucera, Radim
    Staud, Frantisek
    Ceckova, Martina
    BIOCHEMICAL PHARMACOLOGY, 2018, 154 : 10 - 17
  • [50] Capillary electrophoresis to assess drug metabolism induced in vitro using single CYP450 enzymes (Supersomes™):: Application to the chiral metabolism of mephenytoin and methadone
    Prost, F
    Thormann, W
    ELECTROPHORESIS, 2003, 24 (15) : 2577 - 2587
12345